The global peripheral neuropathy treatment market was valued at USD 764.27 Million in 2024 and is projected to reach USD 1099.09 Million by 2034, growing at a CAGR of 3.70%. The market is driven by the increasing prevalence of chronic diseases such as diabetes and cancer, which elevate the risk of developing peripheral neuropathy among patients. https://www.expertmarketresearch.com/reports/peripheral-neuropathy-treatment-market